Skip to main content

EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc., Thousand Oaks, CA 91320, NDC 55513-880-02.

Drug Recall

Official source record

Recall number
D-0539-2025
Event ID
97110
Classification
Class II
Status
Ongoing
Recalling company
Mckesson Medical-Surgical Inc. Corporate Office
Reason for recall
CGMP Deviations; potential temperature excursions due to transit delays
Report date
July 30, 2025
Recall initiation date
April 21, 2025
Termination date
Not terminated as of this source record
Distribution pattern
Within the U.S - OH, VA, FL.

Drug product identifiers

Manufacturer
Amgen, Inc
Brand name
EVENITY
Generic name
ROMOSOZUMAB-AQQG
Substance name
ROMOSOZUMAB
Product NDCs
55513-509; 55513-880; 55513-998
Package NDCs
55513-509-01; 55513-509-02; 55513-880-01; 55513-880-02; 55513-998-01; 55513-998-02
Route
SUBCUTANEOUS

Where this information comes from

View FDA enforcement record -- the specific openFDA drug enforcement record this summary was built from.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for details.

Retrieved by Public Health Trace:

Frequently asked questions

What does a Class II mean?

A situation in which use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote.

Is this recall still active?

According to the FDA, this recall's status is "Ongoing." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this medication?

Do not start, stop, or change any medication based on this page. Follow the instructions published by the FDA and the recalling company (see the source links below), and talk to your pharmacist or physician if you have questions about a specific medication.

Where can I find more official information?

The source links below, published by the FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

Public Health Trace republishes official FDA drug recall information -- it is not affiliated with the FDA, does not verify or supplement what the source has published, and does not provide medical advice. Never start, stop, or change a medication based on this page. Always follow the guidance of your pharmacist or physician, and consult the official source links above for the most current information. Read the full medical disclaimer.